[ad_1]
This decision was made taking into account that currently Lithuania has already approved 0.7 million. for the purchase of doses of this vaccine, which will be delivered in 2021. end of the year and will guarantee the need for vaccination.
The Ministry of Health also notes that the vaccine is not attractive for donation due to low interest from states in this vaccine.
“We see that this vaccine is also not of interest to other countries, which means that we could not even use it for donation,” said Health Minister Arūnas Dulkys.
According to the ministry, the Janssen vaccine is also not suitable for maintaining immunity due to its platform.
This vaccine is also suitable for immunity and is very effective, but we are talking here and looking to the future: the years 2022-2023 and the data shows that if we look ahead, new strains, variations, variants of the virus and if we “go to think about future revaccinations, then the platform of this vaccine is not suitable for that, “the minister explained at the government meeting.
It was also seconded by Prime Minister Ingrida Šimonytė.
“In fact, it appears that in terms of future vaccinations, the ability of the manufacturer to tailor its vaccine to any emerging variant will be very important, because until everyone is vaccinated, there is a risk of those variants,” said I. Šimonytė.
No part of this publication may be reproduced without the written permission of ELTA.
[ad_2]
